Analysts Set Cooper Companies Inc (NYSE:COO) PT at $322.20

Cooper Companies Inc (NYSE:COO) has earned an average recommendation of “Buy” from the thirteen ratings firms that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and ten have assigned a buy rating to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $322.20.

Several equities analysts recently commented on the stock. KeyCorp cut their target price on shares of Cooper Companies from $351.00 to $348.00 and set an “overweight” rating for the company in a research note on Friday, October 11th. Wells Fargo & Co upped their target price on shares of Cooper Companies from $356.00 to $365.00 and gave the company an “outperform” rating in a research note on Thursday, August 8th. Piper Jaffray Companies set a $360.00 target price on shares of Cooper Companies and gave the company a “buy” rating in a research note on Friday, August 30th. ValuEngine cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Tuesday, September 10th. Finally, Raymond James reiterated a “buy” rating on shares of Cooper Companies in a research note on Monday, August 26th.

In other news, Director Allan E. Rubenstein sold 1,335 shares of the stock in a transaction on Wednesday, September 11th. The shares were sold at an average price of $299.61, for a total value of $399,979.35. Following the completion of the transaction, the director now owns 3,591 shares in the company, valued at approximately $1,075,899.51. The sale was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 1.70% of the company’s stock.

Hedge funds have recently made changes to their positions in the company. Ossiam bought a new stake in shares of Cooper Companies in the 2nd quarter worth about $25,000. Flagship Harbor Advisors LLC grew its holdings in shares of Cooper Companies by 62.5% in the 2nd quarter. Flagship Harbor Advisors LLC now owns 78 shares of the medical device company’s stock worth $26,000 after purchasing an additional 30 shares during the last quarter. Kings Point Capital Management bought a new stake in shares of Cooper Companies in the 2nd quarter worth about $27,000. Evolution Wealth Advisors LLC bought a new stake in shares of Cooper Companies in the 2nd quarter worth about $34,000. Finally, NumerixS Investment Technologies Inc bought a new stake in shares of Cooper Companies in the 2nd quarter worth about $34,000. Institutional investors own 95.69% of the company’s stock.

NYSE:COO traded up $3.71 during trading hours on Friday, hitting $305.69. 356,873 shares of the company traded hands, compared to its average volume of 320,896. The stock has a market capitalization of $14.85 billion, a price-to-earnings ratio of 26.58, a P/E/G ratio of 2.20 and a beta of 0.90. Cooper Companies has a twelve month low of $228.65 and a twelve month high of $344.32. The firm has a 50-day moving average of $291.98 and a 200 day moving average of $310.25. The company has a current ratio of 1.29, a quick ratio of 0.73 and a debt-to-equity ratio of 0.39.

Cooper Companies (NYSE:COO) last released its earnings results on Thursday, August 29th. The medical device company reported $3.23 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.16 by $0.07. The firm had revenue of $679.40 million during the quarter, compared to analysts’ expectations of $687.60 million. Cooper Companies had a net margin of 17.08% and a return on equity of 17.15%. The business’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same period in the prior year, the company earned $3.00 EPS. Equities research analysts predict that Cooper Companies will post 12.32 earnings per share for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Featured Story: Fibonacci Channel

Analyst Recommendations for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.